Interestingly, an increased incidence of venous thromboembolism has also been observed in the setting of HGF/MET inhibition possibly supporting the notion that anti-HGF/MET drugs can disrupt the functioning of the vascular endothelium. Here, HGF is linked to venous thromboembolism.